147 related articles for article (PubMed ID: 7696286)
1. Pharmacokinetic variability in the adolescent: implications of body size and organ function for dosage regimen design.
Rodman JH
J Adolesc Health; 1994 Dec; 15(8):654-62. PubMed ID: 7696286
[TBL] [Abstract][Full Text] [Related]
2. Guidelines on paediatric dosing on the basis of developmental physiology and pharmacokinetic considerations.
Bartelink IH; Rademaker CM; Schobben AF; van den Anker JN
Clin Pharmacokinet; 2006; 45(11):1077-97. PubMed ID: 17048973
[TBL] [Abstract][Full Text] [Related]
3. Body surface area for adjustment of drug dose.
Drug Ther Bull; 2010 Mar; 48(3):33-6. PubMed ID: 20200147
[TBL] [Abstract][Full Text] [Related]
4. Lean body mass as a predictor of drug dosage. Implications for drug therapy.
Morgan DJ; Bray KM
Clin Pharmacokinet; 1994 Apr; 26(4):292-307. PubMed ID: 8013162
[TBL] [Abstract][Full Text] [Related]
5. Discontinuities and disruptions in drug dosage guidelines for the paediatric population.
Chitty KM; Chan B; Pulanco CL; Luu S; Egunsola O; Buckley NA
Br J Clin Pharmacol; 2018 May; 84(5):1029-1037. PubMed ID: 29411410
[TBL] [Abstract][Full Text] [Related]
6. A simplified weight-based method for pediatric drug dosing for zidovudine and didanosine in resource-limited settings.
Weidle PJ; Abrams EJ; Gvetadze R; Rivadeneira E; Kline MW
Pediatr Infect Dis J; 2006 Jan; 25(1):59-64. PubMed ID: 16395105
[TBL] [Abstract][Full Text] [Related]
7. Calculation of drug dosage and body surface area of children.
Lack JA; Stuart-Taylor ME
Br J Anaesth; 1997 May; 78(5):601-5. PubMed ID: 9175982
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin dosing in children and young adults: back to the drawing board.
Camaione L; Elliott K; Mitchell-Van Steele A; Lomaestro B; Pai MP
Pharmacotherapy; 2013 Dec; 33(12):1278-87. PubMed ID: 24019205
[TBL] [Abstract][Full Text] [Related]
9. Indexing glomerular filtration rate to suit children.
Bird NJ; Henderson BL; Lui D; Ballinger JR; Peters AM
J Nucl Med; 2003 Jul; 44(7):1037-43. PubMed ID: 12843217
[TBL] [Abstract][Full Text] [Related]
10. Developmental changes in the liver weight- and body weight-normalized clearance of theophylline, phenytoin and cyclosporine in children.
Kanamori M; Takahashi H; Echizen H
Int J Clin Pharmacol Ther; 2002 Nov; 40(11):485-92. PubMed ID: 12698985
[TBL] [Abstract][Full Text] [Related]
11. Drug dosing based on weight and body surface area: mathematical assumptions and limitations in obese adults.
Pai MP
Pharmacotherapy; 2012 Sep; 32(9):856-68. PubMed ID: 22711238
[TBL] [Abstract][Full Text] [Related]
12. A systematic comparison of cockcroft-gault and modification of diet in renal disease equations for classification of kidney dysfunction and dosage adjustment.
Park EJ; Wu K; Mi Z; Dong T; Lawrence JP; Ko CW; Huang SM; Zhang L; Crentsil V; Zhang J; Xu NN
Ann Pharmacother; 2012 Sep; 46(9):1174-87. PubMed ID: 22932303
[TBL] [Abstract][Full Text] [Related]
13. Optimizing pediatric dosing: a developmental pharmacologic approach.
Anderson GD; Lynn AM
Pharmacotherapy; 2009 Jun; 29(6):680-90. PubMed ID: 19476420
[TBL] [Abstract][Full Text] [Related]
14. Essentials for starting a pediatric clinical study (1): Pharmacokinetics in children.
Yokoi T
J Toxicol Sci; 2009; 34 Suppl 2():SP307-12. PubMed ID: 19571484
[TBL] [Abstract][Full Text] [Related]
15. Radiopharmaceutical dosage selection for pediatric nuclear medicine.
Shore RM; Hendee WR
J Nucl Med; 1986 Feb; 27(2):287-98. PubMed ID: 3712045
[TBL] [Abstract][Full Text] [Related]
16. Developmental pharmacokinetics.
Anderson GD
Semin Pediatr Neurol; 2010 Dec; 17(4):208-13. PubMed ID: 21183126
[TBL] [Abstract][Full Text] [Related]
17. Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.
Kendrick JG; Carr RR; Ensom MH
Clin Ther; 2015 Sep; 37(9):1897-923. PubMed ID: 26361823
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients.
Pescovitz MD; Ettenger RB; Strife CF; Sherbotie JR; Thomas SE; McDiarmid S; Bartosh S; Ives J; Bouw MR; Bucuvalas J
Transpl Infect Dis; 2010 Jun; 12(3):195-203. PubMed ID: 20002356
[TBL] [Abstract][Full Text] [Related]
19. Practical treatment guide for dose individualisation in cancer chemotherapy.
Canal P; Chatelut E; Guichard S
Drugs; 1998 Dec; 56(6):1019-38. PubMed ID: 9878990
[TBL] [Abstract][Full Text] [Related]
20. Population pharmacokinetics and pharmacokinetics/pharmacodynamics of bendamustine in pediatric patients with relapsed/refractory acute leukemia.
Darwish M; Megason G; Bond M; Hellriegel E; Robertson P; Grasela T; Phillips L
Curr Med Res Opin; 2014 Nov; 30(11):2305-15. PubMed ID: 25105914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
